Received Nov 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | U8790AA | OT / RA |
administering the vaccine, the needle snapped and the product trickled down my arm with no reported adverse event; administering the vaccine, the needle snapped and the product trickled down my arm with no reported adverse event; Initial information received on 30-Oct-2025 (with live follow up attached on same day) regarding an unsolicited valid non-serious case received from a consumer/non-hcp. This case involves a 51 years old female patient who received the influenza trivalent recombinant vaccine [flublok TIV], the needle snapped and the product trickled down my arm with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 12-Sep-2025, the patient received 0.5 ml of suspect influenza trivalent recombinant vaccine Solution for injection (Unknown strength) with lot U8790AA and expiry date 30-APR-2026 via intramuscular route in the right arm for Prophylactic vaccination (immunization), the needle snapped and the product trickled down my arm with no reported adverse event (accidental exposure to product) (exposure via skin contact) (Latency same day) Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.